From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance

From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance

Monoclonal gammopathy and peripheral neuropathy are common diseases of elderly patients, and almost 10% of patients with neuropathy of unknown cause have paraprotein. However, growing evidence suggests that several hematological malignancies synthesize and release monoclonal proteins that damage the...

Full description

Bibliographic Details
Main Authors:	Andrea Visentin, Stefano Pravato, Francesca Castellani, Marta Campagnolo, Francesco Angotzi, Chiara Adele Cavarretta, Alessandro Cellini, Valeria Ruocco, Alessandro Salvalaggio, Alessandra Tedeschi, Livio Trentin, Chiara Briani
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Cancers
Subjects:	monoclonal gammopathies of neurological significance (MGNS) anti-myelin-associated-glycoprotein (MAG) polyneuropathy POEMS syndrome Castleman’s disease ibrutinib rituximab
Online Access:	https://www.mdpi.com/2072-6694/14/6/1562

Similar Items

Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies
by: Johannes P. M. van de Mortel, et al.
Published: (2022-10-01)

Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report
by: Shiran Paranavitane, et al.
Published: (2019-12-01)

Pseudoscleroderma associated with POEMS syndrome
by: Kalina Wysocka-Dubielecka, et al.
Published: (2019-12-01)

Megaloblastic anemia with peripheral neuropathy, a misleading initial presentation in POEMS syndrome: A case report
by: Iadarilang Tiewsoh, et al.
Published: (2014-01-01)

Clinical spectrum of POEMS-associated multicentric Castleman disease with renal involvement: a diagnostic challenge
by: Caroline Kullmann Ribeiro, et al.
Published: (2019-04-01)

Cutaneous Manifestations in POEMS Syndrome: Case Report and Review
by: Flauberto Sousa Marinho, et al.
Published: (2015-04-01)

Demyelinating Polyradiculoneuropathy in Chronic Lymphocytic Leukemia: A Case Report on BTKis versus Venetoclax-Rituximab
by: Alessandro Cellini, et al.
Published: (2023-12-01)

Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies
by: Chiara Briani, et al.
Published: (2021-01-01)

Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib
by: Hajime Yasuda, et al.
Published: (2022-10-01)

Polyclonal Immunotactoid Glomerulopathy Associated with Monoclonal Gammopathy of IgM Type and Underlying Plasmacellular Disease: Successful Treatment with Rituximab Alone
by: Wolfgang Neukirchen, et al.
Published: (2022-04-01)

Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases
by: Francesco Angotzi, et al.
Published: (2022-02-01)

Doença de Castleman localizada abdominal Abdominal Castleman's disease
by: Cássio V. C. Oliveira, et al.
Published: (2005-06-01)

Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy
by: Woo Kyung Sung, et al.
Published: (2015-06-01)

A Rare Association between Idiopathic Multicentric Castleman Disease, Nephrotic Syndrome and Polyneuropathy in an immunocompetent patient
by: Luís Landeiro, et al.
Published: (2021-10-01)

CASTLEMAN DISEASE VARIANT OF POEMS SYNDROME. A CASE REPORT
by: Pedro Paolo Sotelo, et al.
Published: (2019-10-01)

A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease
by: Alexandra Butzmann, et al.
Published: (2021-03-01)

Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment
by: Artem Oganesyan, et al.
Published: (2022-11-01)

Induction immunotherapy followed by surgery for hilar unicentric Castleman disease
by: Fumihiro Shoji, et al.
Published: (2022-06-01)

A rare HIV-associated hyaline vascular multicentric castleman disease with good early response to single-agent rituximab: A case from Tanzania
by: William Frank Mawalla, et al.
Published: (2022-11-01)

Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
by: Louis-Pierre Girard, et al.
Published: (2022-06-01)

Monoclonal gammopathy associated with visceral leishmaniasis
by: Vishal Sharma, et al.

POEMS Syndrome: Two Case Reports
by: Turgay Demir, et al.
Published: (2015-06-01)

Doença de Castleman e Síndrome de POEMS: relato de caso e revisão da literatura
by: Bianca Fontana, et al.
Published: (2008-08-01)

Glomeruloid hemangioma in normal individuals
by: Jyoti Gupta, et al.
Published: (2013-01-01)

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
by: Andrea Visentin, et al.
Published: (2022-11-01)

CASE OF THE LATE DIAGNOSIS OF POEMS-SYNDROME
by: P. N. Barlamov, et al.
Published: (2014-07-01)

CASE OF THE LATE DIAGNOSIS OF POEMS-SYNDROME
by: P. N. Barlamov, et al.
Published: (2014-07-01)

Monoclonal Gammopathy of Thrombotic Significance
by: Vasiliki Gkalea, et al.
Published: (2023-01-01)

Raynaud’s phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report
by: Fabio Torres-Saavedra, et al.
Published: (2022-05-01)

Lichen myxedematosus associated with monoclonal gammopathy of undetermined significance: A case report and literature review
by: Hua Huang, et al.
Published: (2023-03-01)

POEMS Sendromu: İki Olgu Sunumu
by: Turgay DEMİR, et al.
Published: (2015-09-01)

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study
by: Francesca Romana Mauro, et al.
Published: (2021-12-01)

Oligosecretory monoclonal gammopathy with renal involvement
by: L V Kozlovskaya, et al.
Published: (2016-12-01)

C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance
by: Inês Gomes-Alves, et al.
Published: (2021-05-01)

Kidney injury associated with monoclonal gammopathies: Perspectives on diagnosis and treatment
by: L V Kozlovskaya, et al.
Published: (2015-06-01)

Biclonal gammopathy – A single-center experience
by: Geetha Narayanan, et al.
Published: (2023-01-01)

Multicentric vs. Unresectable Unicentric Castleman Disease with Active Presentation: An Orphan Rare Disease in a Young Egyptian Female Patient. A Case Report
by: Yasmine Shaaban, et al.
Published: (2023-06-01)

Editorial: Monoclonal gammopathies of clinical significance: Clinical and therapeutic implications
by: Chen Wang, et al.
Published: (2023-01-01)

Monoclonal Gammopathies in a Series of 1743 Plasma Donors
by: Vladimír Maisnar, et al.
Published: (2006-01-01)

CASTLEMAN DISEASE VARIANT OF POEMS SYNDROME: A CASE REPORT AND LITERATURE REVIEW
by: LI Yuxin, XU Xiang, ZHANG Xiaolin, XING Baodi, ZHAO Wenjuan, HAO Dapeng, LIU Bin, CHEN Yunqing, DONG Bingzi, WANG Zhongchao, SUN Xiaofang, ZHAO Yuhang
Published: (2023-12-01)